{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:41:18Z","timestamp":1792078878396,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016939","name":"Myriad Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016939","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.psychres.2020.113649","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T18:10:01Z","timestamp":1608142201000},"page":"113649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression"],"prefix":"10.1016","volume":"296","author":[{"given":"Anthony J.","family":"Rothschild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar V.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6113-5521","authenticated-orcid":false,"given":"Daniel","family":"Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Thase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boadie W.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"DeBattista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent P.","family":"Forester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-4208","authenticated-orcid":false,"given":"Richard C.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Macaluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Greden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2020.113649_bib0001","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/tpj.2014.85","article-title":"Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes","volume":"15","author":"Altar","year":"2015","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.psychres.2020.113649_bib0002","series-title":"The GeneSight Psychotropic Combinatorial Algorithm","author":"Assurex Health","year":"2020"},{"key":"10.1016\/j.psychres.2020.113649_bib0003","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41397-018-0027-3","article-title":"Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools","volume":"18","author":"Bousman","year":"2018","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.psychres.2020.113649_bib0004","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1081\/DMR-200033482","article-title":"The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man","volume":"36","author":"Breyer-Pfaff","year":"2004","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.psychres.2020.113649_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1535370217733425","article-title":"Biomarkers of adverse drug reactions","volume":"243","author":"Carr","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.psychres.2020.113649_bib0006","series-title":"Clinical and Translational Science","author":"Caudle","year":"2019"},{"key":"10.1016\/j.psychres.2020.113649_bib0007","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2146\/ajhp150946","article-title":"Implementation of inpatient models of pharmacogenetics programs","volume":"73","author":"Cavallari","year":"2016","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.psychres.2020.113649_bib0008","author":"CDC","year":"2010"},{"key":"10.1016\/j.psychres.2020.113649_bib0009","series-title":"Prioritization: Assignment of CPIC Levels for Genes\/Drugs [Online]","author":"CPIC","year":"2019"},{"key":"10.1016\/j.psychres.2020.113649_bib0010","author":"CPIC","year":"2020","journal-title":"Prioritization of CPIC Guidelines [Online]"},{"key":"10.1016\/j.psychres.2020.113649_bib0011","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2146\/ajhp160072","article-title":"Implementation of a multidisciplinary pharmacogenomics clinic in a community health system","volume":"73","author":"Dunnenberger","year":"2016","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.psychres.2020.113649_bib0012","series-title":"Pharmacogenomics: Overview of the Genomics and Targeted Therapy Group [Online]. U.S. Food & Drug Administration","author":"FDA","year":"2020"},{"key":"10.1016\/j.psychres.2020.113649_bib0013","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/164_2018_161","article-title":"Therapeutic Drug Monitoring of Antidepressants","volume":"250","author":"Fiaturi","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.psychres.2020.113649_bib0014","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.euroneuro.2017.06.009","article-title":"Escitalopram plasma levels and antidepressant response","volume":"27","author":"Florio","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2020.113649_bib0015","series-title":"Practice guideline for the treatment of patients with major depressive disorder","author":"Gelenberg","year":"2010"},{"key":"10.1016\/j.psychres.2020.113649_bib0016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpsychires.2019.01.003","article-title":"Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study","volume":"111","author":"Greden","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2020.113649_bib0017","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/FPC.0b013e3283649b9a","article-title":"Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting","volume":"23","author":"Hall-Flavin","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.psychres.2020.113649_bib0018","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1038\/tp.2012.99","article-title":"Using a pharmacogenomic algorithm to guide the treatment of depression","volume":"2","author":"Hall-Flavin","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113649_bib0019","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cpt.147","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors","volume":"98","author":"Hicks","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2020.113649_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2020.113649_bib0021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/FPC.0000000000000392","article-title":"PharmGKB summary: sertraline pathway, pharmacokinetics","volume":"30","author":"Huddart","year":"2020","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.psychres.2020.113649_bib0022","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2217\/pme-2017-0094","article-title":"Analytical validation of a psychiatric pharmacogenomic test","volume":"15","author":"Jablonski","year":"2018","journal-title":"Personal. Med."},{"key":"10.1016\/j.psychres.2020.113649_bib0023","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1176\/appi.ajp.2017.17050550","article-title":"Impact of CYP2C19 genotype on escitalopram exposure and therapeutic failure: a retrospective study based on 2,087 patients","volume":"175","author":"Juki\u0107","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113649_bib0024","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can. J. Psychiatry. Revue Canadienne de Psychiatrie"},{"key":"10.1016\/j.psychres.2020.113649_bib0025","series-title":"Pharmacogenetics [Online].The Royal Dutch Pharmacists Association","author":"Knmp","year":"2020"},{"key":"10.1016\/j.psychres.2020.113649_bib0026","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/ejhg.2010.101","article-title":"A standardized framework for the validation and verification of clinical molecular genetic tests","volume":"18","author":"Mattocks","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.psychres.2020.113649_bib0027","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/14737167.2017.1385395","article-title":"The challenges of implementing pharmacogenomic testing in the clinic","volume":"17","author":"MOYER","year":"2017","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.psychres.2020.113649_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e328340bc5a","article-title":"CYP2C19 variation and citalopram response","volume":"21","author":"Mrazek","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.psychres.2020.113649_bib0029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12991-017-0140-8","article-title":"Smoking and antidepressants pharmacokinetics: a systematic review","volume":"16","author":"Oliveira","year":"2017","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113649_bib0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00004714-199408000-00002","article-title":"Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response","volume":"14","author":"Perry","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.113649_bib0031","series-title":"Amitriptyline and Nortriptyline Pathway, Pharmacokinetics [Online]","author":"Pharmgkb","year":"2019"},{"key":"10.1016\/j.psychres.2020.113649_bib0032","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2020.113649_bib0033","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41431-018-0095-5","article-title":"How is genetic testing evaluated? A systematic review of the literature","volume":"26","author":"Pitini","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.psychres.2020.113649_bib0034","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euroneuro.2011.10.003","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy","volume":"22","author":"Porcelli","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2020.113649_bib0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jad.2018.08.056","article-title":"The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis","volume":"241","author":"Rosenblat","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2020.113649_bib0036","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113649_bib0037","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/FPC.0b013e328346063f","article-title":"PharmGKB summary: citalopram pharmacokinetics pathway","volume":"21","author":"Sangkuhl","year":"2011","journal-title":"Pharmacogen. Genom."},{"key":"10.1016\/j.psychres.2020.113649_bib0038","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/164_2018_164","article-title":"Serotonin and Norepinephrine Reuptake Inhibitors","volume":"250","author":"Shelton","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.psychres.2020.113649_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113017","article-title":"Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder","volume":"290","author":"Shelton","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2020.113649_bib0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/17425255.2015.1021684","article-title":"Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety","volume":"11","author":"Sultana","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.psychres.2020.113649_bib0041","author":"U.S. Department of health and human services food and drug administration","year":"2020"},{"key":"10.1016\/j.psychres.2020.113649_bib0042","first-page":"219","article-title":"A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder","volume":"16","author":"Winner","year":"2013","journal-title":"Discov. Med."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120333102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120333102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:43:26Z","timestamp":1759038206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178120333102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":42,"alternative-id":["S0165178120333102"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113649","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113649"}}